Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

425 Press Releases
DateTitleCompany
19 Aug 17 Boehringer Ingelheim anuncia resultados positivos em todas as unidades de negócios Boehringer Ingelheim ,
Published by
PharmiWeb.com
27 Jul 17 Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA® Boehringer Ingelheim,
Published by
Business Wire
24 Jul 17 Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility Boehringer Ingelheim,
Published by
PharmiWeb.com
14 Jun 17 Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA® Boehringer Ingelheim,
Published by
Business Wire
24 May 17 New Analyses Show SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Improves Breathing for People with Asthma Regardless of BMI or Allergic Status Boehringer Ingelheim ,
Published by
PharmiWeb.com
24 May 17 IPF patients treated with Ofev® (nintedanib) versus placebo were twice as likely to have improved or stable lung function Boehringer Ingelheim ,
Published by
PharmiWeb.com
24 May 17 IPF patients treated with Ofev® (nintedanib) versus placebo were twice as likely to have improved or stable lung function Boehringer Ingelheim Pharmaceuticals,
Published by
PR Newswire
23 May 17 ATS 2017 Spiriva® Respimat® improves breathing for people with asthma regardless of BMI or allergic status Boehringer Ingelheim,
Published by
Business Wire
16 May 17 Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University Boehringer Ingelheim,
Published by
Business Wire
16 May 17 Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China Boehringer Ingelheim,
Published by
Business Wire
05 Apr 17 Boehringer Ingelheim: A New World Leader in Animal Health Boehringer Ingelheim,
Published by
Business Wire
30 Mar 17 Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries Boehringer Ingelheim,
Published by
PharmiWeb.com
30 Mar 17 Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries Boehringer Ingelheim,
Published by
PR Newswire
28 Mar 17 Yankees Baseball Legend Bernie Williams Raises Awareness of Devastating Lung Disease - IPF - in Honor of his Dad Boehringer Ingelheim,
Published by
PR Newswire
21 Mar 17 Uninterrupted Pradaxa® (dabigatran etexilate mesylate) Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation Boehringer Ingelheim Pharmaceuticals,
Published by
PharmiWeb.com
21 Mar 17 Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases Boehringer Ingelheim ,
Published by
PharmiWeb.com
20 Mar 17 Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases Boehringer Ingelheim,
Published by
Business Wire
20 Mar 17 Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation Boehringer Ingelheim,
Published by
Business Wire
22 Nov 16 Survey Reveals Most People Don't Know Heart Disease Is the No. 1 Killer of People with Type 2 Diabetes Boehringer Ingelheim and Eli Lilly and Company,
Published by
PR Newswire
07 Dec 16 Limited improvement in EGFR testing rates observed in new survey with approximately one in five advanced lung cancer patients still at risk of missing out on targeted therapy Boehringer Ingelheim Pharmaceuticals, Inc.,
Published by
PR Newswire
27 Feb 17 Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin Boehringer Ingelheim ,
Published by
PharmiWeb.com
29 Nov 16 Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss Boehringer Ingelheim ,
Published by
PharmiWeb.com
27 Oct 16 Boehringer Ingelheim Named One of Science Magazine's Top Employers for the Twelfth Consecutive Year Boehringer Ingelheim Pharmaceuticals, Inc.,
Published by
PR Newswire
15 Feb 17 Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments Boehringer Ingelheim,
Published by
Business Wire
08 Dec 16 Boehringer Ingelheim Awarded Perfect Score for Workplace Equality for the LGBT Community Boehringer Ingelheim Pharmaceuticals, Inc.,
Published by
PR Newswire
18 Jan 17 Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review Boehringer Ingelheim,
Published by
PR Newswire
15 Dec 16 BASAGLAR® (insulin glargine injection 100 units/mL), A Long-Acting Basal Insulin, Is Now Available in U.S. Eli Lilly and Company; Boehringer Ingelheim,
Published by
PR Newswire
16 Feb 17 US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment of Asthma in Children Boehringer Ingelheim,
Published by
Business Wire
02 Jan 17 Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017 Boehringer Ingelheim,
Published by
Business Wire
02 Mar 17 Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers Boehringer Ingelheim,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.